NOELIA
GRANADO MARTÍNEZ
Researcher to 2020
Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas
Madrid, EspañaPublications in collaboration with researchers from Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (20)
2021
-
Amino-Cupric-Silver (A-Cu-Ag) Staining to Detect Neuronal Degeneration in the Mouse Brain: The de Olmos Technique
Neuromethods (Humana Press Inc.), pp. 3-19
-
Behavioral sensitization and cellular responses to psychostimulants are reduced in D2R knockout mice
Addiction Biology, Vol. 26, Núm. 1
2020
-
Modeling Parkinson’s Disease With the Alpha-Synuclein Protein
Frontiers in Pharmacology, Vol. 11
2018
-
Striatal Reinnervation Process after Acute Methamphetamine-Induced Dopaminergic Degeneration in Mice
Neurotoxicity Research, Vol. 34, Núm. 3, pp. 627-639
2017
-
Amphetamine-related drugs neurotoxicity in humans and in experimental animals: Main mechanisms
Progress in Neurobiology, Vol. 155, pp. 149-170
2016
-
Fragment C domain of tetanus toxin mitigates methamphetamine neurotoxicity and its motor consequences in mice
International Journal of Neuropsychopharmacology, Vol. 19, Núm. 8, pp. 1-11
2015
-
Methamphetamine-Induced Toxicity in Indusium Griseum of Mice is Associated with Astro- and Microgliosis
Neurotoxicity Research, Vol. 27, Núm. 3, pp. 209-216
2014
-
D1 but not D4 dopamine receptors are critical for MDMA-induced neurotoxicity in mice
Neurotoxicity Research, Vol. 25, Núm. 1, pp. 100-109
-
Methamphetamine causes degeneration of dopamine cell bodies and terminals of the nigrostriatal pathway evidenced by silver staining
Neuropsychopharmacology, Vol. 39, Núm. 5, pp. 1066-1080
-
Neurotoxicity of methamphetamine
Handbook of Neurotoxicity (Springer New York), pp. 2207-2230
2013
-
Cocaine potentiates MDMA-induced oxidative stress but not dopaminergic neurotoxicity in mice: Implications for the pathogenesis of free radical-induced neurodegenerative disorders
Psychopharmacology, Vol. 230, Núm. 1, pp. 125-135
-
Methamphetamine and parkinson's disease
Parkinson's Disease
-
Neurobiology of Methamphetamine
Biological Research on Addiction (Elsevier Inc.), pp. 579-591
-
Neurobiology of Methamphetamine
Biological Research on Addiction: Comprehensive Addictive Behaviors and Disorders (Elsevier), pp. 579-591
-
The role of dopamine receptors in the neurotoxicity of methamphetamine
Journal of Internal Medicine, Vol. 273, Núm. 5, pp. 437-453
2012
-
Dopamine D 1 receptor deletion strongly reduces neurotoxic effects of methamphetamine
Neurobiology of Disease, Vol. 45, Núm. 2, pp. 810-820
2011
-
Dopamine D2-receptor knockout mice are protected against dopaminergic neurotoxicity induced by methamphetamine or MDMA
Neurobiology of Disease, Vol. 42, Núm. 3, pp. 391-403
2010
-
Genetic inactivation of Pleiotrophin triggers amphetamine-induced cell loss in the substantia nigra and enhances amphetamine neurotoxicity in the striatum
Neuroscience, Vol. 170, Núm. 1, pp. 308-316
2008
-
Early loss of dopaminergic terminals in striosomes after MDMA administration to mice
Synapse, Vol. 62, Núm. 1, pp. 80-84
-
Persistent MDMA-induced dopaminergic neurotoxicity in the striatum and substantia nigra of mice
Journal of Neurochemistry, Vol. 107, Núm. 4, pp. 1102-1112